Search Results - "Accardi, Fabrizio"
-
1
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
Published in Leukemia (01-01-2022)“…Immune profiling in patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM)…”
Get full text
Journal Article -
2
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
Published in Blood (04-08-2016)“…The importance of glutamine (Gln) metabolism in multiple myeloma (MM) cells and its potential role as a therapeutic target are still unknown, although it has…”
Get full text
Journal Article -
3
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Published in BioMed research international (01-01-2015)“…Multiple myeloma (MM) is characterized by a high capacity to induce alterations in the bone remodeling process. The increase in osteoclastogenesis and the…”
Get full text
Journal Article -
4
The Proteasome and Myeloma-Associated Bone Disease
Published in Calcified tissue international (01-02-2018)“…Bone disease is the hallmark of multiple myeloma (MM), a hematological malignancy characterized by osteolytic lesions due to a severe uncoupled and unbalanced…”
Get full text
Journal Article -
5
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors
Published in Journal of bone and mineral research (01-04-2016)“…ABSTRACT Multiple myeloma (MM) is characterized by severely imbalanced bone remodeling. In this study, we investigated the potential effect of proteasome…”
Get full text
Journal Article -
6
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience
Published in Haematologica (Roma) (31-10-2024)“…Not available.Not available…”
Get full text
Journal Article -
7
CD38 expression by plasma cells in extramedullary multiple myeloma
Published in Haematologica (Roma) (01-04-2024)Get full text
Journal Article -
8
-
9
IL21R expressing CD14 + CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts
Published in Haematologica (Roma) (01-04-2017)“…Bone marrow monocytes are primarily committed to osteoclast formation. It is, however, unknown whether potential primary alterations are specifically present…”
Get full text
Journal Article -
10
Multiple Myeloma in 2023 Ways: From Trials to Real Life
Published in Current oncology (Toronto) (01-11-2023)“…Multiple myeloma is a chronic hematologic malignancy that obstinately tends to relapse. Basic research has made giant strides in better characterizing the…”
Get full text
Journal Article -
11
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
Published in International journal of hematology (2017)“…The skin is a possible site of extramedullary localization in multiple myeloma (MM) patients; however, the mechanisms involved in this process are poorly…”
Get full text
Journal Article -
12
-
13
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis
Published in Case reports in hematology (01-01-2018)“…Muscle involvement in AL amyloidosis is a rare condition, and the diagnosis of amyloid myopathy is often delayed and underdiagnosed. Amyloid myopathy may be…”
Get full text
Journal Article -
14
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Published in Hematology reports (03-04-2018)“…The association between Neurofibromatosis type I (NF1) and multiple myeloma (MM), a plasma cell, dyscrasia is very rare. Here we put to the attention of the…”
Get full text
Journal Article -
15
The osteoblastic niche in the context of multiple myeloma
Published in Annals of the New York Academy of Sciences (01-01-2015)“…The osteoblastic niche has a critical role in the regulation of hemopoietic stem cell (HSC) quiescence and self‐renewal and in the support of hematopoiesis…”
Get full text
Journal Article -
16
-
17
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
Published in Oncotarget (22-08-2017)“…It is known that multiple myeloma (MM) cells express CD38 and that a recently developed human anti-CD38 monoclonal antibody Daratumumab mediates myeloma…”
Get full text
Journal Article -
18
Novel targets for the treatment of relapsing multiple myeloma
Published in Expert review of hematology (03-07-2019)“…: Multiple myeloma (MM) is characterized by the high tendency to relapse and develop drug resistance. : This review focused on the main novel targets…”
Get more information
Journal Article -
19
Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass
Published in Blood (13-11-2019)“…The identification of risk factors for progression is critical in the clinical management and appropriate follow up of patients with pre-malignant Asymptomatic…”
Get full text
Journal Article -
20